Entasis Therapeutics opens at $13.45, IPO priced at $15.00 per share
Entasis Therapeutics (ETTX) priced 5M shares at $15.00. The deal size was increased to 5M shares from 4.1M shares and priced below the $16.00-$18.00 range. Credit Suisse and BMO Capital acted as joint book running managers for the offering.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.